NEW YORK, May 3, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Halyard Health, Inc. ("Halyard" or the "Company") (NYSE: HYH). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 237.
The investigation concerns whether Halyard and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On May 1, 2016, 60 Minutes reported that Halyard knowingly provided defective surgical gowns to U.S. workers at the height of the Ebola crisis. A Company insider claimed that Halyard manufactured and sold surgical gowns that were prone to leaks and did not consistently meet the industrial safety standards for the treatment of Ebola.
On this news, Halyard stock fell $1.21, or 4.3%, to close at $26.95 on May 2, 2016.
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-halyard-health-inc--hyh-300261966.html
SOURCE Pomerantz LLP